Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 91

    1.

    Novel germline MSH2 mutation in lynch syndrome patient surviving multiple cancers.

    Janavicius R, Elsakov P.

    Hered Cancer Clin Pract. 2012 Jan 10;10(1):1.

    PMID:
    22234272
    [PubMed - in process]
    Free PMC Article
    2.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    3.

    Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer.

    Lin KM, Shashidharan M, Thorson AG, Ternent CA, Blatchford GJ, Christensen MA, Watson P, Lemon SJ, Franklin B, Karr B, Lynch J, Lynch HT.

    J Gastrointest Surg. 1998 Jan-Feb;2(1):67-71.

    PMID:
    9841970
    [PubMed - indexed for MEDLINE]
    4.

    Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome.

    Medina-Arana V, Delgado L, González L, Bravo A, Díaz H, Salido E, Riverol D, González-Aguilera JJ, Fernández-Peralta AM.

    Fam Cancer. 2011 Jun;10(2):265-71.

    PMID:
    21225464
    [PubMed - indexed for MEDLINE]
    5.

    The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.

    Watson P, Vasen HF, Mecklin JP, Bernstein I, Aarnio M, Järvinen HJ, Myrhøj T, Sunde L, Wijnen JT, Lynch HT.

    Int J Cancer. 2008 Jul 15;123(2):444-9.

    PMID:
    18398828
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum.

    Stulp RP, Herkert JC, Karrenbeld A, Mol B, Vos YJ, Sijmons RH.

    Hered Cancer Clin Pract. 2008 Feb 15;6(1):15-21.

    PMID:
    19706203
    [PubMed]
    Free PMC Article
    7.

    The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome.

    Stuckless S, Parfrey PS, Woods MO, Cox J, Fitzgerald GW, Green JS, Green RC.

    Fam Cancer. 2007;6(1):1-12.

    PMID:
    17039271
    [PubMed - indexed for MEDLINE]
    8.

    Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.

    Gargiulo S, Torrini M, Ollila S, Nasti S, Pastorino L, Cusano R, Bonelli L, Battistuzzi L, Mastracci L, Bruno W, Savarino V, Sciallero S, Borgonovo G, Nyström M, Bianchi-Scarrà G, Mareni C, Ghiorzo P.

    Fam Cancer. 2009;8(4):547-53.

    PMID:
    19728162
    [PubMed - indexed for MEDLINE]
    9.

    [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].

    Czakó L, Tiszlavicz L, Takács R, Baradnay G, Lonovics J, Cserni G, Závodná K, Bartosova Z.

    Orv Hetil. 2005 May 15;146(20):1009-16. Hungarian.

    PMID:
    15945244
    [PubMed - indexed for MEDLINE]
    10.

    Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population.

    Lin KM, Shashidharan M, Ternent CA, Thorson AG, Blatchford GJ, Christensen MA, Lanspa SJ, Lemon SJ, Watson P, Lynch HT.

    Dis Colon Rectum. 1998 Apr;41(4):428-33.

    PMID:
    9559626
    [PubMed - indexed for MEDLINE]
    11.

    Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium.

    Goecke T, Schulmann K, Engel C, Holinski-Feder E, Pagenstecher C, Schackert HK, Kloor M, Kunstmann E, Vogelsang H, Keller G, Dietmaier W, Mangold E, Friedrichs N, Propping P, Krüger S, Gebert J, Schmiegel W, Rueschoff J, Loeffler M, Moeslein G; German HNPCC Consortium.

    J Clin Oncol. 2006 Sep 10;24(26):4285-92. Epub 2006 Aug 14.

    PMID:
    16908935
    [PubMed - indexed for MEDLINE]
    12.
    13.

    Analysis of EPCAM protein expression in diagnostics of Lynch syndrome.

    Kloor M, Voigt AY, Schackert HK, Schirmacher P, von Knebel Doeberitz M, Bläker H.

    J Clin Oncol. 2011 Jan 10;29(2):223-7. Epub 2010 Nov 29.

    PMID:
    21115857
    [PubMed - indexed for MEDLINE]
    14.

    Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States.

    Kastrinos F, Stoffel EM, Balmaña J, Steyerberg EW, Mercado R, Syngal S.

    Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2044-51.

    PMID:
    18708397
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.

    Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, DeVine DA, Lau J.

    Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180. Review.

    PMID:
    17764220
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Spectrum of MLH1 and MSH2 mutations in Chilean families with suspected Lynch syndrome.

    Alvarez K, Hurtado C, Hevia MA, Wielandt AM, de la Fuente M, Church J, Carvallo P, López-Köstner F.

    Dis Colon Rectum. 2010 Apr;53(4):450-9.

    PMID:
    20305446
    [PubMed - indexed for MEDLINE]
    17.

    Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion.

    Lynch HT, Riegert-Johnson DL, Snyder C, Lynch JF, Hagenkord J, Boland CR, Rhees J, Thibodeau SN, Boardman LA, Davies J, Kuiper RP, Hoogerbrugge N, Ligtenberg MJ.

    Am J Gastroenterol. 2011 Oct;106(10):1829-36. doi: 10.1038/ajg.2011.203. Epub 2011 Jul 19.

    PMID:
    21769135
    [PubMed - indexed for MEDLINE]
    18.

    Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia.

    Zavodna K, Bujalkova M, Krivulcik T, Alemayehu A, Skorvaga M, Marra G, Fridrichova I, Jiricny J, Bartosova Z.

    Neoplasma. 2006;53(4):269-76.

    PMID:
    16830052
    [PubMed - indexed for MEDLINE]
    19.

    Final Report on Carcinogens Background Document for Styrene.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.

    PMID:
    20737009
    [PubMed - as supplied by publisher]
    20.

    A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome.

    Perera S, Ramyar L, Mitri A, Pollett A, Gallinger S, Speevak MD, Aronson M, Bapat B.

    J Hum Genet. 2010 Jan;55(1):37-41. Epub 2009 Nov 13.

    PMID:
    19911012
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk